Cost minimization analysis of treatment with intravenous or subcutaneous trastuzumab in patients with HER2-positive breast cancer in Spain

  1. Lopez-Vivanco, G.
  2. Salvador, J.
  3. Diez, R.
  4. López, D.
  5. De Salas-Cansado, M.
  6. Navarro, B.
  7. De la Haba-Rodríguez, J.
Journal:
Clinical and Translational Oncology

ISSN: 1699-3055,  1699-048X

Year of publication: 2017

Volume: 19

Issue: 12

Pages: 1454-1461

Type: Article

DOI: 10.1007/S12094-017-1684-4 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus